About Gems Biogenics Private Limited
Data last updated:
Gems Biogenics Private Limited is a private limited company based in Howrah, West Bengal, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 24 July 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24100WB2014PTC202676. Its GSTIN is 19AAFCG6800J1ZH (West Bengal).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹40 Lakh. It is led by directors Arup Kumar Banerjee and Krishna Banerjee.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. G – 1 Ground Floor 18 Swami Vivekananda Road, Howrah, West Bengal, India – 711101.
As per the financials filed for FY 2024, the company reported a revenue of ₹38.83 Lakh. For the same year it recorded a net profit of ₹57,269 (net margin 1.5%) and EBITDA of ₹61,443 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over five years.
As per MCA filings, the company has satisfied charges of ₹30 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website gemsbiogenics.com.
Company details
Contact details
Gems Biogenics Private Limited's registered office is in Howrah, West Bengal. Its website is gemsbiogenics.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressFlat No. G – 1 Ground Floor 18 Swami Vivekananda Road, Howrah, West Bengal, India – 711101
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Gems Biogenics Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Gems Biogenics is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Gems Biogenics Private Limited, buy the company report.
Financials of Gems Biogenics Private Limited
FY 2025 filings availableGems Biogenics Private Limited reported revenue of ₹38.83 Lakh for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years. EBITDA fell 1% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹61,443 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57,269 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.6% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Gems Biogenics Private Limited, buy the company report.
Board of directors of Gems Biogenics Private Limited
Gems Biogenics has 2 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arup Kumar Banerjee | Director | 17 Aug 2019 | 7 Years 2 Months | Current |
| Krishna Banerjee | Director | 17 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Gems Biogenics Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Integral Biotech Private Limited | ₹38.94 Lakh (FY 2025) | 2.0% | Patna, Bihar, India | |||
| Geokem Pharmaceuticals Private Limited | ₹38.91 Lakh (FY 2020) | 117.0% | Hyderabad, Telangana, India | |||
| Dosedrugs Remedies Private Limited | ₹38.9 Lakh (FY 2025) | 23.0% | Kolhapur, Maharashtra, India | |||
| Gems Biogenics Private Limitedthis company | ₹38.83 Lakh (FY 2024) | ₹57,269 | 1.5% | Howrah, West Bengal, India | ||
| Vyomax Life Sciences Private Limited | ₹38.73 Lakh (FY 2023) | 56.0% | Jabalpur, Madhya Pradesh, India |
To see the full peer comparison of Gems Biogenics Private Limited, buy the company report.
Auditor
Gems Biogenics Private Limited is audited by S. N. DAS & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S. N. DAS & ASSOCIATES | FY 2017 | 320013E |
Shareholding
The shareholding of Gems Biogenics Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Gems Biogenics Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Dec 2015 | 10606955 | Bank of India | ₹30 Lakh | Satisfied |
To see the full charge records of Gems Biogenics Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Gems Biogenics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Gems Biogenics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Gems Biogenics has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAFCG6800J1ZH | West Bengal | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Gems Biogenics Private Limited, buy the company report.
Recent activity
Gems Biogenics Private Limited has 9 board changes on record since 2016: 2 appointments and 7 cessations. The latest: Gautam Jana ceased to be Director on 15 Sep 2020.
2 earlier events are in the company report.
Frequently asked questions
Gems Biogenics is an active private limited company based in Howrah, West Bengal, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 24 July 2014 (12+ years old) and is registered under CIN U24100WB2014PTC202676.
Gems Biogenics has 2 current directors:
- Arup Kumar Banerjee - Director
- Krishna Banerjee - Director
The latest financial statements of Gems Biogenics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Gems Biogenics is 19AAFCG6800J1ZH, registered in West Bengal.
The CIN (Corporate Identification Number) of Gems Biogenics is U24100WB2014PTC202676. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gems Biogenics was incorporated on 24 July 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Gems Biogenics by revenue are Integral Biotech Private Limited, Geokem Pharmaceuticals Private Limited, Dosedrugs Remedies Private Limited, Vyomax Life Sciences Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Gautam Jana ceased to be Director on 15 Sep 2020. Sandipan Chatterjee ceased to be Director on 15 Sep 2020. Arup Kumar Banerjee was appointed as Director on 17 Aug 2019. Gems Biogenics has 9 board changes on record in total.
Gems Biogenics can be reached through the website gemsbiogenics.com. Its registered office is in Howrah, West Bengal, India.
The registered office of Gems Biogenics is at Flat No. G – 1 Ground Floor 18 Swami Vivekananda Road, Howrah, West Bengal, India – 711101.
Gems Biogenics operates in the pharma industry, in the pharmaceutical retailers and distributors segment.